• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchReplimune
    Picture of Replimune logo

    REPL — Replimune News Story

    $11.990.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapMomentum Trap
    • Market Cap
      $1.13bn
    • Enterprise Value
      $1.04bn
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • REPL Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    REPL Dividends
    All News

    NASDAQ RESUMED AT 07:50 PM

    Picture of Replimune logoReplimune
    31/07/2026 24:50
    NASDAQ RESUMED  AT 07:50 PM

    Recent news on Replimune

    See all news
    • Trump picks White House adviser Heidi Overton to run FDA, source says (updated)

      19/08/2026 01:35
    • Brief: Replimune Group, Inc. Files For Mixed Shelf Size Not Disclosed

      14/08/2026 21:54
    • Brief: Replimune Reports Fiscal First Quarter 2027 Financial Results And Provides Corporate Update

      14/08/2026 13:40
    • Replimune Q1 net loss narrows as expenses decline

      14/08/2026 13:14
    • U.S. STOCKS ON THE MOVE-Microsoft, Coastal Financial, Eli Lilly

      10/08/2026 18:47

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.